Purchase Order HT942525PE014
- Not listed
- This is a $97,350.04 firm fixed-price purchase order awarded by the Defense Health Agency to Qiagen, LLC, a subsidiary of the biotechnology company Qiagen N.V. The contract is for QIAGEN EQUIPMENT MAINTENANCE SERVICES and has a period of performance through September 28, 2024. No set-aside designation was used. Qiagen is a major provider of sample and assay technologies to federal agencies, supporting programs related to biomedical research, public health, law enforcement, and healthcare. This...
- This firm fixed-price purchase order for $14,943.24 was awarded by the Defense Health Agency to Qiagen, LLC, a division of Qiagen N.V., to provide maintenance services for three QIAGEN EZ1 Advanced XL automated nucleic acid systems. The contract has an ultimate completion date of September 29, 2025. This award is not associated with a set-aside program. Qiagen is an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, and...
- This is a $13,858 firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian federal agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer and global provider of sample and assay technologies for molecular diagnostics, applied testing, pharmaceuticals, and academic research. The contract is for the maintenance of QIAGEN laboratory equipment. It does not have a set-aside designation and has an ultimate completion date of May 14, 2028. Qiagen is a...
- The Defense Health Agency awarded a firm-fixed-price purchase order worth $55,002.15 to Qiagen, LLC, a division of the international provider Qiagen N.V., for pathology consultation and laboratory equipment. This award is not associated with a set-aside program. Qiagen has provided a range of products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs through past prime and sub-contract awards, including DNA/RNA extraction kits,...
- This contract award to Qiagen, LLC, a foreign-owned, for-profit manufacturer of molecular diagnostics products, is for the purchase of 10,196 DNeasy UltraClean 96 Microbial Kits. The $78,505.00 Firm Fixed Price contract is a BPA Call and was awarded on June 13, 2025 by the Defense Health Agency, a defense agency. The contract has an ultimate completion date of July 31, 2025 and does not utilize any set-aside designations. Qiagen, LLC is the prime contractor and has been awarded several other...
- This federal contract award, valued at $44,765.50, was made by the Defense Health Agency (DHA) to Qiagen, LLC, a subsidiary of the multinational biotechnology company Qiagen N.V. The contract, which has no set-aside designation, is for the provision of QIASEQ FORCE products, which are likely targeted DNA panels and kits. The original solicitation, issued by the U.S. Army Medical Research Acquisition Activity (USAMRAA), sought qualified sources capable of providing these specialized molecular...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $49,060.00 firm fixed price purchase order to Qiagen, LLC, a division of the international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics, for maintenance on laboratory equipment. The contract has a completion date of June 30, 2023 and was awarded on July 1, 2018. Qiagen has provided a range of goods and services to support federal...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $5,356.00 firm fixed price purchase order to Qiagen, LLC for equipment maintenance services. The award does not have a set-aside designation and is scheduled to be completed by April 18, 2025. Qiagen, LLC is a division of Qiagen N.V., an international provider of sample and assay technologies that supports federal agencies in areas like biomedical research, public health, and law enforcement...
- This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a defense agency, to Qiagen, LLC, a foreign-owned for-profit manufacturer, for $10,026.00 to provide preventative maintenance services for two EZ1 Advanced XL laboratory instruments located at the Naval Medical Research Command's Infectious Diseases Diagnostic Laboratory. The contract has a 12-month period of performance from April 12, 2025 to April 11, 2026 and was awarded without any set-aside designation....
- Qiagen, LLC was awarded a $17,393.80 firm fixed price delivery order by the Defense Health Agency to provide TEST KITS. Qiagen is a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. No set-aside designation was applied to this award. Performance will take place in Germantown, Maryland through September 30, 2024. Qiagen holds several indefinite delivery contracts with federal agencies including...
The Defense Health Agency awarded a $87,964.23 firm fixed price purchase order to Qiagen, LLC on September 30, 2025, for scientific equipment preventive maintenance services supporting the Center of Infectious Disease Research in Support of the Warfighter, with completion scheduled for September 29, 2030. The contract, issued without set-aside designation, will be performed in Silver Spring, Maryland, and covers maintenance services for the contractor's specialized molecular diagnostics and scientific instrumentation. Qiagen, a foreign-owned, for-profit manufacturer headquartered in Germantown, Maryland, is a leading provider of molecular diagnostics, DNA/RNA extraction systems, and advanced laboratory equipment to federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Veterans Affairs, and the Department of Defense. This award stems from a pre-solicitation opportunity posted on February 24, 2025, with a due date of March 4, 2025. Qiagen maintains multiple significant indefinite delivery vehicles across federal agencies, including a $6.5 million blanket purchase agreement with the Defense Health Agency for pharmaceutical products, positioning the company as an established partner for critical defense health research and diagnostic support initiatives. The preventive maintenance agreement ensures the continued operational readiness of specialized equipment used by the Center of Infectious Disease Research, supporting the Department of Defense's broader mission to maintain scientific capabilities essential to military medical readiness and warfighter support.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Ambr 250 High Throughput Bioreactor | HT942525Q0036 | Defense Health Agency | Solicitation 4/5 | 6/17/25, 7:48 AM | |
BRAND NAME Ambr 250 High Throughput bioreactor for WRAIR | HT942525Q0036 | Defense Health Agency | Solicitation 5/5 | 6/17/25, 9:00 AM | |
Ambr 250 High Throughput Bioreactor System | PANDHA25P0000-007301 | Defense Health Agency | Special Notice 2/5 | 3/11/25, 4:24 PM | |
Ambr 250 High Throughput Bioreactor System | PANDHA25P0000-007301 | Defense Health Agency | Pre-Solicitation 1/5 | 2/24/25, 2:28 PM | |
Ambr 250 High Throughput Bioreactor System | HT942525Q0036 | Defense Health Agency | Pre-Solicitation 3/5 | 3/25/25, 11:16 AM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 8/22/25 |